Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Lepu Biopharma Co. Ltd. Class H ( (HK:2157) ) has provided an announcement.
Lepu Biopharma Co., Ltd. announced a change in the composition of its Nomination Committee, with Dr. Pu Zhongjie stepping down and Ms. Pu Jue being appointed as a new member. This change aligns with upcoming amendments to the Listing Rules and Corporate Governance Code, effective July 1, 2025, aimed at enhancing the effectiveness, diversity, and governance practices of the company’s board.
More about Lepu Biopharma Co. Ltd. Class H
Lepu Biopharma Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative therapies and products, primarily targeting the healthcare market.
Average Trading Volume: 24,415,556
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.58B
Find detailed analytics on 2157 stock on TipRanks’ Stock Analysis page.